{"id":3610,"date":"2009-07-29T10:26:01","date_gmt":"2009-07-29T07:26:01","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=3610"},"modified":"2009-07-29T10:26:01","modified_gmt":"2009-07-29T07:26:01","slug":"glaxosmithkline-vade-ve-iskontolarla-ilgili-aciklama","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=3610","title":{"rendered":"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama"},"content":{"rendered":"<p style=\"margin: 0cm 0cm 0pt\" class=\"MsoNormal\"><font face=\"Times New Roman\" size=\"3\">Vade ve iskontolar\u0131 s\u0131n\u0131rlayan ila\u00e7 firmalar\u0131na kar\u015f\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fcm\u00fcz eylem meyvesini vermeye ba\u015flad\u0131.<\/font><\/p>\n<p><font face=\"Times New Roman\" size=\"3\">\u00a0<\/font> <\/p>\n<p style=\"margin: 0cm 0cm 0pt\" class=\"MsoNormal\"><font face=\"Times New Roman\" size=\"3\">&#8220;Servier&#8221; ve &#8220;Merck Sharp Dohme&#8221; ila\u00e7 firmalar\u0131ndan sonra GlaxoSmithKline ila\u00e7 firmas\u0131 da 01.08.2009 tarihinden itibaren ge\u00e7erli olmak \u00fczere t\u00fcm \u00fcr\u00fcnlerinde vadenin en az 90 g\u00fcn olaca\u011f\u0131n\u0131, &#8220;Seretide&#8221; d\u0131\u015f\u0131ndaki \u00fcr\u00fcnlerinde jeneri\u011fi olanlarda %7, olmayanlarda ise %4 olarak ticari \u0131skonto uygulaca\u011f\u0131n\u0131 bildirmi\u015ftir.<\/font><\/p>\n<p><font face=\"Times New Roman\" size=\"3\">\u00a0<\/font> <\/p>\n<p style=\"margin: 0cm 0cm 0pt\" class=\"MsoNormal\"><font face=\"Times New Roman\" size=\"3\">Konuyla ilgili TEB&#8217;in a\u00e7\u0131klamas\u0131 ve &#8220;GlaxoSmithKline&#8221; \u0131n yaz\u0131s\u0131 i\u00e7in <\/font><a href=\"http:\/\/www.ieo.org.tr\/upload\/pdf\/20090729_TEB_Merkez_Heyeti.pdf\"><font face=\"Times New Roman\" size=\"3\">t\u0131klay\u0131n\u0131z<\/font><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vade ve iskontolar\u0131 s\u0131n\u0131rlayan ila\u00e7 firmalar\u0131na kar\u015f\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fcm\u00fcz eylem meyvesini vermeye ba\u015flad\u0131. \u00a0 &#8220;Servier&#8221; ve &#8220;Merck Sharp Dohme&#8221; ila\u00e7 firmalar\u0131ndan&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_monsterinsights_skip_tracking":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-3610","post","type-post","status-publish","format-standard","hentry","category-ced"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"Vade ve iskontolar\u0131 s\u0131n\u0131rlayan ila\u00e7 firmalar\u0131na kar\u015f\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fcm\u00fcz eylem meyvesini vermeye ba\u015flad\u0131. &quot;Servier&quot; ve &quot;Merck Sharp Dohme&quot; ila\u00e7 firmalar\u0131ndan sonra GlaxoSmithKline ila\u00e7 firmas\u0131 da 01.08.2009 tarihinden itibaren ge\u00e7erli olmak \u00fczere t\u00fcm \u00fcr\u00fcnlerinde vadenin en az 90 g\u00fcn olaca\u011f\u0131n\u0131, &quot;Seretide&quot; d\u0131\u015f\u0131ndaki \u00fcr\u00fcnlerinde jeneri\u011fi olanlarda %7, olmayanlarda ise %4 olarak ticari \u0131skonto uygulaca\u011f\u0131n\u0131 bildirmi\u015ftir. Konuyla ilgili TEB&#039;in\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"CED \u0130STANBUL\"\/>\n\t<meta name=\"google-site-verification\" content=\"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA\" \/>\n\t<meta name=\"msvalidate.01\" content=\"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA\" \/>\n\t<meta name=\"p:domain_verify\" content=\"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA\" \/>\n\t<meta name=\"keywords\" content=\"\u00e7ed\" \/>\n\t<link rel=\"canonical\" href=\"http:\/\/www.ced.org.tr\/?p=3610\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.3\" \/>\n\n\t\t<meta name=\"google-site-verification\" content=\"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA\" \/>\n\t\t<meta property=\"og:locale\" content=\"tr_TR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"\u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi\" \/>\n\t\t<meta property=\"og:description\" content=\"Vade ve iskontolar\u0131 s\u0131n\u0131rlayan ila\u00e7 firmalar\u0131na kar\u015f\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fcm\u00fcz eylem meyvesini vermeye ba\u015flad\u0131. &quot;Servier&quot; ve &quot;Merck Sharp Dohme&quot; ila\u00e7 firmalar\u0131ndan sonra GlaxoSmithKline ila\u00e7 firmas\u0131 da 01.08.2009 tarihinden itibaren ge\u00e7erli olmak \u00fczere t\u00fcm \u00fcr\u00fcnlerinde vadenin en az 90 g\u00fcn olaca\u011f\u0131n\u0131, &quot;Seretide&quot; d\u0131\u015f\u0131ndaki \u00fcr\u00fcnlerinde jeneri\u011fi olanlarda %7, olmayanlarda ise %4 olarak ticari \u0131skonto uygulaca\u011f\u0131n\u0131 bildirmi\u015ftir. Konuyla ilgili TEB&#039;in\" \/>\n\t\t<meta property=\"og:url\" content=\"http:\/\/www.ced.org.tr\/?p=3610\" \/>\n\t\t<meta property=\"fb:app_id\" content=\"1929982940611222\" \/>\n\t\t<meta property=\"fb:admins\" content=\"343956055774962,212758298769685,1829947477319551\" \/>\n\t\t<meta property=\"og:image\" content=\"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/cropped-cropped-CEDLOGO.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"208\" \/>\n\t\t<meta property=\"og:image:height\" content=\"144\" \/>\n\t\t<meta property=\"article:tag\" content=\"\u00e7ed\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2009-07-29T07:26:01+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2009-07-29T07:26:01+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/1502807510044536\/\" \/>\n\t\t<meta property=\"article:author\" content=\"http:\/\/\u00c7a\u011fda\u015f%20Eczac\u0131lar%20\u0130stanbul\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@CagdasEczacilar\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Vade ve iskontolar\u0131 s\u0131n\u0131rlayan ila\u00e7 firmalar\u0131na kar\u015f\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fcm\u00fcz eylem meyvesini vermeye ba\u015flad\u0131. &quot;Servier&quot; ve &quot;Merck Sharp Dohme&quot; ila\u00e7 firmalar\u0131ndan sonra GlaxoSmithKline ila\u00e7 firmas\u0131 da 01.08.2009 tarihinden itibaren ge\u00e7erli olmak \u00fczere t\u00fcm \u00fcr\u00fcnlerinde vadenin en az 90 g\u00fcn olaca\u011f\u0131n\u0131, &quot;Seretide&quot; d\u0131\u015f\u0131ndaki \u00fcr\u00fcnlerinde jeneri\u011fi olanlarda %7, olmayanlarda ise %4 olarak ticari \u0131skonto uygulaca\u011f\u0131n\u0131 bildirmi\u015ftir. Konuyla ilgili TEB&#039;in\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@CEDistanbul\" \/>\n\t\t<meta name=\"twitter:image\" content=\"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/CEDLOGO.jpg\" \/>\n\t\t<meta name=\"twitter:label1\" content=\"Taraf\u0131ndan yaz\u0131lm\u0131\u015ft\u0131r\" \/>\n\t\t<meta name=\"twitter:data1\" content=\"CED \u0130STANBUL\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610#article\",\"name\":\"\\u201cGlaxoSmithKline\\u201d vade ve iskontolarla ilgili a\\u00e7\\u0131klama | \\u00c7a\\u011fda\\u015f Eczac\\u0131lar Derne\\u011fi\",\"headline\":\"\\u201cGlaxoSmithKline\\u201d vade ve iskontolarla ilgili a\\u00e7\\u0131klama\",\"author\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\"},\"publisher\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/wp-content\\\/uploads\\\/2014\\\/05\\\/ced_favicon.png\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#articleImage\",\"width\":160,\"height\":169},\"datePublished\":\"2009-07-29T10:26:01+03:00\",\"dateModified\":\"2009-07-29T10:26:01+03:00\",\"inLanguage\":\"tr-TR\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610#webpage\"},\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610#webpage\"},\"articleSection\":\"\\u00c7ED\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#listItem\",\"position\":1,\"name\":\"Ev\",\"item\":\"http:\\\/\\\/www.ced.org.tr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1#listItem\",\"name\":\"\\u00c7ED\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1#listItem\",\"position\":2,\"name\":\"\\u00c7ED\",\"item\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610#listItem\",\"name\":\"\\u201cGlaxoSmithKline\\u201d vade ve iskontolarla ilgili a\\u00e7\\u0131klama\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#listItem\",\"name\":\"Ev\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610#listItem\",\"position\":3,\"name\":\"\\u201cGlaxoSmithKline\\u201d vade ve iskontolarla ilgili a\\u00e7\\u0131klama\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?cat=1#listItem\",\"name\":\"\\u00c7ED\"}}]},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#organization\",\"name\":\"\\u00c7A\\u011eDA\\u015e ECZACILAR DERNE\\u011e\\u0130\",\"description\":\"Herkes i\\u00e7in e\\u015fit, paras\\u0131z, ula\\u015f\\u0131labilir bir sa\\u011fl\\u0131k hizmeti\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/wp-content\\\/uploads\\\/2014\\\/05\\\/ced_favicon.png\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610\\\/#organizationLogo\",\"width\":160,\"height\":169},\"image\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/groups\\\/1502807510044536\\\/\",\"https:\\\/\\\/twitter.com\\\/CagdasEczacilar\",\"https:\\\/\\\/www.instagram.com\\\/cagdaseczacilaristanbul\\\/\"]},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1\",\"name\":\"CED \\u0130STANBUL\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/268db36756a52d57bae55f9ffde5852f0c9bbd270ed5c7941979e1563edc6d07?s=96&d=retro&r=g\",\"width\":96,\"height\":96,\"caption\":\"CED \\u0130STANBUL\"},\"sameAs\":[\"http:\\\/\\\/\\u00c7a\\u011fda\\u015f%20Eczac\\u0131lar%20\\u0130stanbul\",\"@CEDistanbul\"]},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610#webpage\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610\",\"name\":\"\\u201cGlaxoSmithKline\\u201d vade ve iskontolarla ilgili a\\u00e7\\u0131klama | \\u00c7a\\u011fda\\u015f Eczac\\u0131lar Derne\\u011fi\",\"description\":\"Vade ve iskontolar\\u0131 s\\u0131n\\u0131rlayan ila\\u00e7 firmalar\\u0131na kar\\u015f\\u0131 s\\u00fcrd\\u00fcrd\\u00fc\\u011f\\u00fcm\\u00fcz eylem meyvesini vermeye ba\\u015flad\\u0131. \\\"Servier\\\" ve \\\"Merck Sharp Dohme\\\" ila\\u00e7 firmalar\\u0131ndan sonra GlaxoSmithKline ila\\u00e7 firmas\\u0131 da 01.08.2009 tarihinden itibaren ge\\u00e7erli olmak \\u00fczere t\\u00fcm \\u00fcr\\u00fcnlerinde vadenin en az 90 g\\u00fcn olaca\\u011f\\u0131n\\u0131, \\\"Seretide\\\" d\\u0131\\u015f\\u0131ndaki \\u00fcr\\u00fcnlerinde jeneri\\u011fi olanlarda %7, olmayanlarda ise %4 olarak ticari \\u0131skonto uygulaca\\u011f\\u0131n\\u0131 bildirmi\\u015ftir. Konuyla ilgili TEB'in\",\"inLanguage\":\"tr-TR\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#website\"},\"breadcrumb\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?p=3610#breadcrumblist\"},\"author\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\"},\"creator\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/?author=1#author\"},\"datePublished\":\"2009-07-29T10:26:01+03:00\",\"dateModified\":\"2009-07-29T10:26:01+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#website\",\"url\":\"http:\\\/\\\/www.ced.org.tr\\\/\",\"name\":\"\\u00c7a\\u011fda\\u015f Eczac\\u0131lar Derne\\u011fi\",\"description\":\"Herkes i\\u00e7in e\\u015fit, paras\\u0131z, ula\\u015f\\u0131labilir bir sa\\u011fl\\u0131k hizmeti\",\"inLanguage\":\"tr-TR\",\"publisher\":{\"@id\":\"http:\\\/\\\/www.ced.org.tr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","description":"Vade ve iskontolar\u0131 s\u0131n\u0131rlayan ila\u00e7 firmalar\u0131na kar\u015f\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fcm\u00fcz eylem meyvesini vermeye ba\u015flad\u0131. \"Servier\" ve \"Merck Sharp Dohme\" ila\u00e7 firmalar\u0131ndan sonra GlaxoSmithKline ila\u00e7 firmas\u0131 da 01.08.2009 tarihinden itibaren ge\u00e7erli olmak \u00fczere t\u00fcm \u00fcr\u00fcnlerinde vadenin en az 90 g\u00fcn olaca\u011f\u0131n\u0131, \"Seretide\" d\u0131\u015f\u0131ndaki \u00fcr\u00fcnlerinde jeneri\u011fi olanlarda %7, olmayanlarda ise %4 olarak ticari \u0131skonto uygulaca\u011f\u0131n\u0131 bildirmi\u015ftir. Konuyla ilgili TEB'in","canonical_url":"http:\/\/www.ced.org.tr\/?p=3610","robots":"max-image-preview:large","keywords":"\u00e7ed","webmasterTools":{"google-site-verification":"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA","msvalidate.01":"4\/PADeybIVXNi1FWDn2PVVeqiyUv8gGZqu7DNmOEZBNDKJiHEdIk47RKA","p:domain_verify":"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA","miscellaneous":"&lt;meta name=\"google-site-verification\" content=\"-01Tt29FgD8frNEEpRik8kzbF8-9TRCVGsm93a0wCBA\" \/&gt;"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.ced.org.tr\/?p=3610#article","name":"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","headline":"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama","author":{"@id":"http:\/\/www.ced.org.tr\/?author=1#author"},"publisher":{"@id":"http:\/\/www.ced.org.tr\/#organization"},"image":{"@type":"ImageObject","url":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2014\/05\/ced_favicon.png","@id":"http:\/\/www.ced.org.tr\/#articleImage","width":160,"height":169},"datePublished":"2009-07-29T10:26:01+03:00","dateModified":"2009-07-29T10:26:01+03:00","inLanguage":"tr-TR","mainEntityOfPage":{"@id":"http:\/\/www.ced.org.tr\/?p=3610#webpage"},"isPartOf":{"@id":"http:\/\/www.ced.org.tr\/?p=3610#webpage"},"articleSection":"\u00c7ED"},{"@type":"BreadcrumbList","@id":"http:\/\/www.ced.org.tr\/?p=3610#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/#listItem","position":1,"name":"Ev","item":"http:\/\/www.ced.org.tr\/","nextItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=1#listItem","name":"\u00c7ED"}},{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=1#listItem","position":2,"name":"\u00c7ED","item":"http:\/\/www.ced.org.tr\/?cat=1","nextItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?p=3610#listItem","name":"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama"},"previousItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/#listItem","name":"Ev"}},{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?p=3610#listItem","position":3,"name":"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama","previousItem":{"@type":"ListItem","@id":"http:\/\/www.ced.org.tr\/?cat=1#listItem","name":"\u00c7ED"}}]},{"@type":"Organization","@id":"http:\/\/www.ced.org.tr\/#organization","name":"\u00c7A\u011eDA\u015e ECZACILAR DERNE\u011e\u0130","description":"Herkes i\u00e7in e\u015fit, paras\u0131z, ula\u015f\u0131labilir bir sa\u011fl\u0131k hizmeti","url":"http:\/\/www.ced.org.tr\/","logo":{"@type":"ImageObject","url":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2014\/05\/ced_favicon.png","@id":"http:\/\/www.ced.org.tr\/?p=3610\/#organizationLogo","width":160,"height":169},"image":{"@id":"http:\/\/www.ced.org.tr\/?p=3610\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/groups\/1502807510044536\/","https:\/\/twitter.com\/CagdasEczacilar","https:\/\/www.instagram.com\/cagdaseczacilaristanbul\/"]},{"@type":"Person","@id":"http:\/\/www.ced.org.tr\/?author=1#author","url":"http:\/\/www.ced.org.tr\/?author=1","name":"CED \u0130STANBUL","image":{"@type":"ImageObject","@id":"http:\/\/www.ced.org.tr\/?p=3610#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/268db36756a52d57bae55f9ffde5852f0c9bbd270ed5c7941979e1563edc6d07?s=96&d=retro&r=g","width":96,"height":96,"caption":"CED \u0130STANBUL"},"sameAs":["http:\/\/\u00c7a\u011fda\u015f%20Eczac\u0131lar%20\u0130stanbul","@CEDistanbul"]},{"@type":"WebPage","@id":"http:\/\/www.ced.org.tr\/?p=3610#webpage","url":"http:\/\/www.ced.org.tr\/?p=3610","name":"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","description":"Vade ve iskontolar\u0131 s\u0131n\u0131rlayan ila\u00e7 firmalar\u0131na kar\u015f\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fcm\u00fcz eylem meyvesini vermeye ba\u015flad\u0131. \"Servier\" ve \"Merck Sharp Dohme\" ila\u00e7 firmalar\u0131ndan sonra GlaxoSmithKline ila\u00e7 firmas\u0131 da 01.08.2009 tarihinden itibaren ge\u00e7erli olmak \u00fczere t\u00fcm \u00fcr\u00fcnlerinde vadenin en az 90 g\u00fcn olaca\u011f\u0131n\u0131, \"Seretide\" d\u0131\u015f\u0131ndaki \u00fcr\u00fcnlerinde jeneri\u011fi olanlarda %7, olmayanlarda ise %4 olarak ticari \u0131skonto uygulaca\u011f\u0131n\u0131 bildirmi\u015ftir. Konuyla ilgili TEB'in","inLanguage":"tr-TR","isPartOf":{"@id":"http:\/\/www.ced.org.tr\/#website"},"breadcrumb":{"@id":"http:\/\/www.ced.org.tr\/?p=3610#breadcrumblist"},"author":{"@id":"http:\/\/www.ced.org.tr\/?author=1#author"},"creator":{"@id":"http:\/\/www.ced.org.tr\/?author=1#author"},"datePublished":"2009-07-29T10:26:01+03:00","dateModified":"2009-07-29T10:26:01+03:00"},{"@type":"WebSite","@id":"http:\/\/www.ced.org.tr\/#website","url":"http:\/\/www.ced.org.tr\/","name":"\u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","description":"Herkes i\u00e7in e\u015fit, paras\u0131z, ula\u015f\u0131labilir bir sa\u011fl\u0131k hizmeti","inLanguage":"tr-TR","publisher":{"@id":"http:\/\/www.ced.org.tr\/#organization"}}]},"og:locale":"tr_TR","og:site_name":"\u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","og:type":"article","og:title":"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","og:description":"Vade ve iskontolar\u0131 s\u0131n\u0131rlayan ila\u00e7 firmalar\u0131na kar\u015f\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fcm\u00fcz eylem meyvesini vermeye ba\u015flad\u0131. &quot;Servier&quot; ve &quot;Merck Sharp Dohme&quot; ila\u00e7 firmalar\u0131ndan sonra GlaxoSmithKline ila\u00e7 firmas\u0131 da 01.08.2009 tarihinden itibaren ge\u00e7erli olmak \u00fczere t\u00fcm \u00fcr\u00fcnlerinde vadenin en az 90 g\u00fcn olaca\u011f\u0131n\u0131, &quot;Seretide&quot; d\u0131\u015f\u0131ndaki \u00fcr\u00fcnlerinde jeneri\u011fi olanlarda %7, olmayanlarda ise %4 olarak ticari \u0131skonto uygulaca\u011f\u0131n\u0131 bildirmi\u015ftir. Konuyla ilgili TEB'in","og:url":"http:\/\/www.ced.org.tr\/?p=3610","fb:app_id":"1929982940611222","fb:admins":"343956055774962,212758298769685,1829947477319551","og:image":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/cropped-cropped-CEDLOGO.jpg","og:image:width":208,"og:image:height":144,"article:tag":["\u00e7ed"],"article:published_time":"2009-07-29T07:26:01+00:00","article:modified_time":"2009-07-29T07:26:01+00:00","article:publisher":"https:\/\/www.facebook.com\/groups\/1502807510044536\/","article:author":"http:\/\/\u00c7a\u011fda\u015f%20Eczac\u0131lar%20\u0130stanbul","twitter:card":"summary_large_image","twitter:site":"@CagdasEczacilar","twitter:title":"\u201cGlaxoSmithKline\u201d vade ve iskontolarla ilgili a\u00e7\u0131klama | \u00c7a\u011fda\u015f Eczac\u0131lar Derne\u011fi","twitter:description":"Vade ve iskontolar\u0131 s\u0131n\u0131rlayan ila\u00e7 firmalar\u0131na kar\u015f\u0131 s\u00fcrd\u00fcrd\u00fc\u011f\u00fcm\u00fcz eylem meyvesini vermeye ba\u015flad\u0131. &quot;Servier&quot; ve &quot;Merck Sharp Dohme&quot; ila\u00e7 firmalar\u0131ndan sonra GlaxoSmithKline ila\u00e7 firmas\u0131 da 01.08.2009 tarihinden itibaren ge\u00e7erli olmak \u00fczere t\u00fcm \u00fcr\u00fcnlerinde vadenin en az 90 g\u00fcn olaca\u011f\u0131n\u0131, &quot;Seretide&quot; d\u0131\u015f\u0131ndaki \u00fcr\u00fcnlerinde jeneri\u011fi olanlarda %7, olmayanlarda ise %4 olarak ticari \u0131skonto uygulaca\u011f\u0131n\u0131 bildirmi\u015ftir. Konuyla ilgili TEB'in","twitter:creator":"@CEDistanbul","twitter:image":"http:\/\/www.ced.org.tr\/wp-content\/uploads\/2021\/07\/CEDLOGO.jpg","twitter:label1":"Taraf\u0131ndan yaz\u0131lm\u0131\u015ft\u0131r","twitter:data1":"CED \u0130STANBUL"},"aioseo_meta_data":{"post_id":"3610","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2021-01-09 00:02:50","updated":"2025-06-04 00:45:02","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"jetpack_sharing_enabled":true,"jetpack-related-posts":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3610"}],"version-history":[{"count":0,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3610\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3610"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}